Surgical Robots Market Share, Size and Growth Analysis By 2029

The global market for surgical robots is anticipated to grow significantly, reaching approximately US$ 17,647.82 million by 2028, up from US$ 6,839.07 million in 2021. This growth represents a compound annual growth rate (CAGR) of 14.8% from 2022 to 2028.

Several factors are propelling the expansion of the surgical robots market, including an increasing number of surgical procedures and a rise in product launches and regulatory approvals. However, the high costs associated with surgical procedures and the installation of robotic systems pose challenges to market growth.

Surgical robots are primarily employed in minimally invasive surgeries, allowing for precise manipulation of instruments in confined spaces, surpassing human capabilities. This technology encompasses a wide range of procedures, including urological surgeries, orthopedic surgeries, laparoscopic cholecystectomies (gallbladder removals), bariatric surgeries, gynecological surgeries, and more. Data from the Obesity and Metabolic Surgery Society of India indicates that the number of bariatric surgeries in India surged by approximately 86.7% between 2014 and 2018. Additionally, the American Society for Metabolic and Bariatric Surgery reported that around 252,000 weight loss surgeries were conducted in the United States in 2019.

The increasing frequency of surgical procedures necessitates the use of robotic surgical instruments. According to the 2021 National Health Statistics Reports from the Centers for Disease Control and Prevention (CDC), the obesity rate among adults in the U.S. has reached 41.9%, with 19.7% of children and adolescents aged 2-19 years also affected. Severe obesity, defined as a body mass index (BMI) of 40 or higher, affects 9.2% of adults in the U.S. The link between obesity and various serious comorbidities, such as cardiovascular diseases, diabetes, liver disease, chronic kidney disease, osteoarthritis, and cancer, positions obesity as a leading preventable cause of death. Traditional methods of lifestyle modification and pharmacotherapy often fail to achieve sustained long-term weight loss, with only 10% weight loss maintained after one year and 5.3% after eight years. In contrast, the CDC states that bariatric surgery can lead to significant long-term weight loss, with patients losing up to 77% of their excess weight within a year and over 50% after 10-20 years, while also improving obesity-related comorbidities and reducing the risk of major cardiovascular events.

Robotic surgical systems have been developed to overcome the limitations of traditional laparoscopic techniques. While laparoscopic procedures provide a two-dimensional view on a monitor, robotic surgery offers a three-dimensional perspective through a console, enhancing the surgeon's experience as if they are operating directly within the cavity. For example, the Da Vinci Xi system from Intuitive Surgical features an active camera, multi-quadrant access, enhanced motion precision, tremor filtration, and instruments with endo-wrist movements, providing surgeons with exceptional dexterity. Consequently, the adoption of robotic platforms for primary and bariatric surgeries is expected to increase during the forecast period, driven by the rising prevalence of chronic conditions and the growing number of surgical interventions.

Recent advancements in the surgical robots market include:

• July 2022: Siemens Healthineers introduced the CorPath GRX, an FDA-cleared robotic system, to its portfolio for coronary and peripheral interventions in India, significantly impacting the local healthcare sector.


• June 2022: Stryker announced that its Q guidance system received 510(k) approval from the FDA, designed for advanced intraoperative planning and guidance in spinal surgeries, including pediatric applications.


• April 2022: SS Innovations launched its SSI multi-arm telerobotic surgical system in India, priced between US$ 0.54 million and US$ 0.68 million (INR 40-50 million).


• February 2022: Smith + Nephew unveiled the next-generation CORI surgical system in Japan, aimed at enhancing precision in knee arthroplasty.

The overall healthcare costs in North America are rising sharply, with the U.S. health system incurring direct costs of US$ 5.3 billion in 2020. The healthcare sector contributed an additional US$ 60 billion to the overall annual costs in the same year. In 2020, over 40% of the North American population canceled medical appointments, with 13% reporting unmet healthcare needs. The COVID-19 pandemic significantly altered economic conditions and healthcare delivery, leading to a 40% decrease in emergency department visits and a shift towards telemedicine for outpatient appointments and elective procedures.

The global surgical robots market is categorized by components, including instruments & accessories, robotic systems, and services, with the instruments and accessories segment holding the largest market share in 2021. By application, the market is divided into urological, orthopedic, general, gynecological, cardiothoracic, neurosurgery, and other surgical areas, with urological surgery expected to dominate due to the rising incidence of prostatectomy and partial nephrectomy. In terms of end users, hospitals accounted for the largest share in 2021, driven by the increasing number of robotic-assisted surgeries.

Key secondary sources utilized in the analysis of the global surgical robots market include the World Health Organization (WHO), National Health Service (NHS), Centers for Disease Control and Prevention (CDC), Canadian Partnership Against Cancer (CPAC), United States Cancer Statistics (USCS), Globocan Statistics 2020, World Bank Data, North American Free Trade Agreement (NAFTA), and the Australian Institute of Health and Welfare.